Could you explain this in more detail? "Due to its robustness and versatility, regulatory authorities routinely employ non-compartmental analysis to inform their decision-making during drug development and approval processes. Researchers and clinicians can determine the optimal dosing regimen, predict drug clearance and elimination, and assess potential safety concerns by obtaining reliable and accurate estimates of critical pharmacokinetic parameters."